Stay updated with breaking news from Increase Activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Peningkatan aktivitas di Pelabuhan Soekarno-Hatta, Makassar, membuat PT Pelindo IV (Persero) mencetak laba senilai Rp138,37 miliar di semester I/2021. Perolehan itu lebih tinggi 31,2 persen dibandingkan dengan capaian di periode sama tahun lalu.
Published: Apr 19, 2021 BEVERLY HILLS, Calif., April 19, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, reported financial results for the fourth quarter and year ended December 31, 2020. "2020 was a year of robust clinical progress and milestone achievements for GT Biopharma, which allowed us to accomplish a major corporate milestone in listing GT Biopharma on NASDAQ at the ...